# NCT03367702 (NCT03367702)

> Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03367702
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: NRG Oncology
- Conditions: Stage II Prostate Adenocarcinoma AJCC v7
- Interventions: Intensity-Modulated Radiation Therapy; Quality-of-Life Assessment; Questionnaire Administration; Stereotactic Body Radiation Therapy
- Enrollment: 692
- Primary outcome: Incidence of patients-reported gastrointestinal and genitourinary toxicity
- Primary outcome: Disease free survival

## Commentary we found

- X threads: 29
- Podcasts: 3
- YouTube: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=nct03367702

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03367702", "email": "<work email>"}; the inbox owner confirms by the emailed link.